Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Abstract
Increasing evidence demonstrates that neuroplasticity, a fundamental mechanism of neuronal adaptation, is disrupted in mood disorders and in animal models of stress. Here we provide an overview of the evidence that chronic stress, which can precipitate or exacerbate depression, disrupts neuroplasticity, while antidepressant treatment produces opposing effects and can enhance neuroplasticity. We discuss neuroplasticity at different levels: structural plasticity (such as plastic changes in spine and dendrite morphology as well as adult neurogenesis), functional synaptic plasticity, and the molecular and cellular mechanisms accompanying such changes. Together, these studies elucidate mechanisms that may contribute to the pathophysiology of depression. Greater appreciation of the convergence of mechanisms between stress, depression, and neuroplasticity is likely to lead to the identification of novel targets for more efficacious treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“current evidence indicates that impairment in growth factor signaling is associated with depressed mood (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“neurotrophic growth factors and related signaling pathways constitute major players in neuroplasticity”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“In addition, clean-cut evidence shows that antidepressants require neuroplasticity pathways to rescue the observed deficits in neuronal and synaptic plasticity often associated with mood disorders (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“While traditional antidepressants acutely increase synaptic levels of monoamines, their chronic administration leads to changes in structural neuroplasticity that are contemporaneous with their clinical therapeutic effects (10–12).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
In the citing paper
“these changes in neural circuitry are believed to underlie the deficits in learning/memory, mood, motivation, and reward seeking that are characteristic of depression and related disorders (10, 67–74)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120 · cited 1×
“The relationship between psychosocial stressors and the development of depression in susceptible individuals has long been apparent (Kendler et al, 1999; Caspi et al, 2003).”
BackgroundNeurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
The Organization of Behavior; A Neuropsychological Theory.
Attneave, F., B., M., & Hebb, D. O. (1950) · The American Journal of Psychology · doi:10.2307/1418888 · Cited by 5,146
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“As neurogenesis appears to be required for the behavioral response to antidepressants in rodents (Santarelli et al, 2003; see below) and impaired neurogenesis has been hypothesized to represent a core pathophysiological feature of major depression (Duman, 2004), this effect represents yet another…”
BackgroundSelf-citationThe Organization of Behavior: A Neuropsychological Theory
(1950) · Journal of the American Medical Association · doi:10.1001/jama.1950.02910470083028 · Cited by 4,195
Malenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917 · cited 2×
“CREB, and other inducible transcription factors, induce effector genes that contribute to the stabilization of synaptic plasticity (Kandel, 2001).”
BackgroundEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Research works printed but not linked: 3
- American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders (DSM) IV-TR. American Psychiatric Press: Washington, DC.
- Nemeroff CB (2006). Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psych 66 (S8): 13–21.
- O'Connor JJ, Rowan MJ, Anwyl R (1993). Naunyn Schmiedebergs Arch. Pharmacology 348: 158–163.
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
“hippocampus by chronic antidepressant treatment [2,53,68,69].”
McEwen, B. S., & Gianaros, P. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05331.x · Cited by 1,715
Kandola, A., Ashdown-Franks, G., Hendrikse, J., Sabiston, C. M., & Stubbs, B. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.040 · Cited by 1,309
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Depression and risk of developing dementia
Byers, A. L., & Yaffe, K. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.60 · Cited by 1,265
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207
“A preponderance of evidence from a combination of human imaging, postmortem studies, and animal models suggests that atrophy of neurons in the prefrontal cortex (PFC) plays a key role in the pathophysiology of depression and related disorders and is precipitated and/or exacerbated by stress (Arnsten, 2009; Autry and M…”
BackgroundStress- and Allostasis-Induced Brain Plasticity
McEwen, B. S., & Gianaros, P. J. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-052209-100430 · Cited by 1,171
“Moreover, there is increasing support for the notion that targeting the plasticity of the hippocampus in depression and mood disorders may underpin pharmacological and nonpharmacological treatment efficacy (17, 18).”
The future of sex and gender in psychology: Five challenges to the gender binary.
Hyde, J. S., Bigler, R. S., Joel, D., Tate, C. C., & van Anders, S. M. (2019) · American Psychologist · doi:10.1037/amp0000307 · Cited by 983
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
“…inducing dendritic remodeling, synaptic spine reductions, glial loss, and possibly volumetric reductions resembling those observed in depressed patients (Gorman and Docherty, 2010; Holmes and Wellman, 2009; McEwen, 2005; Musazzi et al., 2011; Pittenger and Duman, 2008; Shansky and Morrison, 2009).”
BackgroundInfluentialThe GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Long-term depression in the CNS
Collingridge, G. L., Peineau, S., Howland, J. G., & Wang, Y. T. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2867 · Cited by 926
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression
Cole, E. J., Stimpson, K. H., Bentzley, B. S., Gulser, M., Cherian, K., Tischler, C., Nejad, R., Pankow, H., Choi, E., Aaron, H., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19070720 · Cited by 802
“degree of treatment resistance display neuroplasticity impairments (61).”
BackgroundNeurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 660
“…it is increasingly appreciated that impairments in synaptic plasticity render a given neural circuit less flexible and adaptable and may represent a primary substrate underlying the transition of chronic stress into mental illness (Calabrese et al, 2009; McEwen, 2012a; Pittenger and Duman, 2008).”
BackgroundThe effects of aging in the hippocampus and cognitive decline
Bettio, L. E. B., Rajendran, L., & Gil-Mohapel, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.030 · Cited by 649
“and atrophy of several encephalic structures, particularly the hippocampus (Pittenger and Duman, 2007).”
Linking Molecules to Mood: New Insight Into the Biology of Depression
Krishnan, V., & Nestler, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.10030434 · Cited by 643
Kreisel, T., Frank, M. G., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M. V., Maier, S. F., & Yirmiya, R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.155 · Cited by 663
The organization of the stress system and its dysregulation in depressive illness
Gold, P. W. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.163 · Cited by 654
The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex
Liu, W., Ge, T., Leng, Y., Pan, Z., Fan, J., Yang, W., & Cui, R. (2017) · Neural Plasticity · doi:10.1155/2017/6871089 · Cited by 640
Synaptic potentiation onto habenula neurons in the learned helplessness model of depression
Li, B., Piriz, J., Mirrione, M., Chung, C., Proulx, C. D., Schulz, D., Henn, F., & Malinow, R. (2011) · Nature · doi:10.1038/nature09742 · Cited by 634
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
de Bodinat, C., Guardiola-Lemaitre, B., Mocaër, E., Renard, P., Muñoz, C., & Millan, M. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3140 · Cited by 593
Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603
Bessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598
Neurogenesis and generalization: a new approach to stratify and treat anxiety disorders
Kheirbek, M. A., Klemenhagen, K. C., Sahay, A., & Hen, R. (2012) · Nature Neuroscience · doi:10.1038/nn.3262 · Cited by 508
Nagy, C., Maitra, M., Tanti, A., Suderman, M., Théroux, J.-F., Davoli, M. A., Perlman, K., Yerko, V., Wang, Y. C., Tripathy, S. J., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0621-y · Cited by 532
Animal Models of Depression: Molecular Perspectives
Krishnan, V., & Nestler, E. J. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2010_108 · Cited by 528
“…and other growth factors like VEGF (vascular endothelial growth factor) and VGF (nonacronymic), which promote the proliferation and differentiation of hippocampal progenitors and alter monoaminergic synaptic transmission (Balu and Lucki 2009; Krishnan and Nestler 2008; Pittenger and Duman 2008).”
BackgroundNagy, C., Maitra, M., Tanti, A., Suderman, M., Théroux, J.-F., Mechawar, N., Ragoussis, J., & Turecki, G. (2018) · doi:10.1101/384479 · Cited by 523
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
“Also like CREB, BDNF levels are ecreased in the brains of suicide victims studied post-mortem, ut increased by pre-mortem antidepressant treatment (Karege t al., 2005; Pittenger and Duman, 2008).”
BackgroundFunctional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 474
“These findings are consistent with the hypothesis that the actions of antidepressants are due, in part, to BDNFinduced neuronal plasticity and/or protection (Pittenger and Duman, 2007).”
BackgroundResultSelf-citationFonken, L. K., Xu, X., Weil, Z. M., Chen, G., Sun, Q., Rajagopalan, S., & Nelson, R. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.76 · Cited by 483
Animal models of major depression: drawbacks and challenges
Planchez, B., Surget, A., & Belzung, C. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02084-y · Cited by 480
Phillips, C. (2017) · Neural Plasticity · doi:10.1155/2017/7260130 · Cited by 450
(2017) · doi:10.1017/s003329171600355x · Cited by 467
“…that are involved in the pathophysiology of depression, including loss of neuroplasticity, inhibition of neurogenesis, increased inflammation and disturbance of circadian rhythm (McEwen, 2004, 2012; Pittenger & Duman, 2007; Pariante & Lightman, 2008; KronfeldSchor & Einat, 2012; Gold, 2015).”
BackgroundDynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
“However, prolonged KOR signaling in response to chronic or uncontrollable stress may lead to persistent changes in behavior that are characteristic of those seen in human depressive disorders (see Kessler, 1997; Nestler and Carlezon, 2006; Pittenger and Duman, 2008).”
BackgroundInfluentialDendritic Spines in Depression: What We Learned from Animal Models
Qiao, H., Li, M.-X., Xu, C., Chen, H.-B., An, S.-C., & Ma, X.-M. (2016) · Neural Plasticity · doi:10.1155/2016/8056370 · Cited by 446
The hippocampal–prefrontal pathway: The weak link in psychiatric disorders?
Godsil, B. P., Kiss, J. P., Spedding, M., & Jay, T. M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.10.018 · Cited by 434
“, 2009), whereas more potent and/or chronic stressors have been shown to trigger dendritic remodeling (Pittenger and Duman, 2008), neuron atrophy (Cerqueira et al.”
The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease
Amidfar, M., de Oliveira, J., Kucharska, E., Budni, J., & Kim, Y.-K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118020 · Cited by 410
Biomarkers for depression: recent insights, current challenges and future prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114542 · Cited by 415
McEwen, B. S., Chattarji, S., Diamond, D. M., Jay, T. M., Reagan, L. P., Svenningsson, P., & Fuchs, E. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.80 · Cited by 406
Hertenstein, E., Trinca, E., Wunderlin, M., Schneider, C. L., Züst, M. A., Fehér, K. D., Su, T., Straten, A. V., Berger, T., Baglioni, C., et al. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101597 · Cited by 391
Elhai, J. D., Levine, J. C., Alghraibeh, A. M., Alafnan, A. A., Aldraiweesh, A. A., & Hall, B. J. (2018) · Computers in Human Behavior · doi:10.1016/j.chb.2018.08.020 · Cited by 330
Activating positive memory engrams suppresses depression-like behaviour
Ramirez, S., Liu, X., MacDonald, C. J., Moffa, A., Zhou, J., Redondo, R. L., & Tonegawa, S. (2015) · Nature · doi:10.1038/nature14514 · Cited by 380
Rugulies, R., Aust, B., & Madsen, I. E. (2017) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.3632 · Cited by 372
“Third, some stud - ies indicated that ERI may lead to dysregulation of the hypothalamic-pituitary-adrenal (HPA) stress axis (18) that is one of several biological pathways considered in the etiology of depressive disorders (19–21).”
Kishimoto, T., Chawla, J. M., Hagi, K., Zarate, C. A., Kane, J. M., Bauer, M., & Correll, C. U. (2016) · Psychological Medicine · doi:10.1017/s0033291716000064 · Cited by 359
“Recent studies demonstrated the role of glutamatemediated neuroplasticity in the pathophysiology of mood disorders and antidepressant effects of glutamatergic agents (Tardito et al. 2006; Pittenger & Duman, 2008; Sanacora et al. 2008).”
BackgroundMoriguchi, S., Takamiya, A., Noda, Y., Horita, N., Wada, M., Tsugawa, S., Plitman, E., Sano, Y., Tarumi, R., ElSalhy, M., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0252-9 · Cited by 357
Timing of light exposure affects mood and brain circuits
Bedrosian, T. A., & Nelson, R. J. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.262 · Cited by 356
The Role of BDNF in Depression on the Basis of Its Location in the Neural Circuitry
Yu, H., & Chen, Z.-Y. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.184 · Cited by 343
Hinwood, M., Tynan, R. J., Charnley, J. L., Beynon, S. B., Day, T. A., & Walker, F. R. (2013) · Cerebral Cortex · doi:10.1093/cercor/bhs151 · Cited by 332
“Chronic stress is recognized to be capable of producing profound alterations in mood and cognitive function (Pittenger and Duman 2008).”
BackgroundCurrent perspectives of the roles of the central norepinephrine system in anxiety and depression
Goddard, A. W., Ball, S. G., Martinez, J., Robinson, M. J., Yang, C. R., Russell, J. M., & Shekhar, A. (2010) · Depression and Anxiety · doi:10.1002/da.20642 · Cited by 316
Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets
Caraci, F., Copani, A., Nicoletti, F., & Drago, F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.022 · Cited by 314
“both for depression (Pittenger and Duman, 2008) and Alzheimer's disease (Bao et al.”
BackgroundSynaptic plasticity in depression: Molecular, cellular and functional correlates
Marsden, W. N. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.012 · Cited by 317
Neuronal plasticity: A link between stress and mood disorders
Calabrese, F., Molteni, R., Racagni, G., & Riva, M. A. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.014 · Cited by 301
“Hence, during the last decade it has become well accepted the idea that this delay is required in order to produce neuroadaptive mechanisms that may enhance neuronal plasticity and resilience (Castren, 2005; Kozisek et al., 2008; Pittenger and Duman, 2008).”
BackgroundAdult hippocampal neurogenesis is functionally important for stress-induced social avoidance
Lagace, D. C., Donovan, M. H., DeCarolis, N. A., Farnbauch, L. A., Malhotra, S., Berton, O., Nestler, E. J., Krishnan, V., & Eisch, A. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910072107 · Cited by 314
“Stress is generally associated with decreased SGZ proliferation, leading to decreased survival and neurogenesis (1, 6).”
BackgroundSerotonin receptors involved in antidepressant effects
Artigas, F. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.006 · Cited by 311
Air Pollution, Stress, and Allostatic Load: Linking Systemic and Central Nervous System Impacts
Thomson, E. M. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190015 · Cited by 290
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
Duric, V., Banasr, M., Stockmeier, C. A., Simen, A. A., Newton, S. S., Overholser, J. C., Jurjus, G. J., Dieter, L., & Duman, R. S. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000016 · Cited by 304
“Using lists of significantly upand down-regulated genes (fold change >1.5 and 0.7, p 0.05), MetaCore allowed for classification according to canonical pathways and signalling networks containing one or more regulated genes.”
InfluentialSelf-citationMicroglial Dysregulation in Psychiatric Disease
Frick, L. R., Williams, K., & Pittenger, C. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/608654 · Cited by 299
Self-citationMusazzi, L., Milanese, M., Farisello, P., Zappettini, S., Tardito, D., Barbiero, V. S., Bonifacino, T., Mallei, A., Baldelli, P., Racagni, G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008566 · Cited by 289
“[3,36–40].”
Spiking Neural Networks Hardware Implementations and Challenges: A Survey
Bouvier, M., Valentian, A., Mesquida, T., Rummens, F., Reyboz, M., Vianello, E., & Beigne, E. (2019) · ACM Journal on Emerging Technologies in Computing Systems · doi:10.1145/3304103 · Cited by 267
“It involves connectional structure modification, synapse adaptation, and others [143].”
BackgroundMechanistic insights and perspectives involved in neuroprotective action of quercetin
Grewal, A. K., Singh, T. G., Sharma, D., Sharma, V., Singh, M., Rahman, M. H., Najda, A., Walasek-Janusz, M., Kamel, M., Albadrani, G. M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111729 · Cited by 285
Social Defeat as an Animal Model for Depression
Hollis, F., & Kabbaj, M. (2014) · ILAR Journal · doi:10.1093/ilar/ilu002 · Cited by 273
Lukić, I., Getselter, D., Ziv, O., Oron, O., Reuveni, E., Koren, O., & Elliott, E. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0466-x · Cited by 273
Naismith, S. L., Norrie, L. M., Mowszowski, L., & Hickie, I. B. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.009 · Cited by 270
Ketamine and the next generation of antidepressants with a rapid onset of action
Machado-Vieira, R., Salvadore, G., DiazGranados, N., & Zarate, C. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.010 · Cited by 276
“In this context, stress and neuroplasticity have also been shown to play a role in MDD, and these are also critically regulated by the glutamatergic system (Pittenger & Duman, 2008).”
BackgroundSterner, E. Y., & Kalynchuk, L. E. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.03.005 · Cited by 260
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Galts, C. P. C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil-Mohapel, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.002 · Cited by 269
Yu, H., Wang, D.-D., Wang, Y., Liu, T., Lee, F. S., & Chen, Z.-Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5048-11.2012 · Cited by 275
“It has been well established that both genetic and environmental factors, such as age, gender, and nutrition, influence the endocrine stress responses (Pittenger and Duman, 2008; Feder et al., 2009; Gillespie et al., 2009; Lupien et al., 2009).”
BackgroundRugulies, R., Aust, B., Greiner, B. A., Arensman, E., Kawakami, N., LaMontagne, A. D., & Madsen, I. E. H. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00869-3 · Cited by 217
Masi, G., & Brovedani, P. (2011) · CNS Drugs · doi:10.2165/11595900-000000000-00000 · Cited by 260
An excitatory synapse hypothesis of depression
Thompson, S. M., Kallarackal, A. J., Kvarta, M. D., Van Dyke, A. M., LeGates, T. A., & Cai, X. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.03.003 · Cited by 265
Role of kappa-opioid receptors in stress and anxiety-related behavior
Van’t Veer, A., & Carlezon, W. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3195-5 · Cited by 257
“In addition to causing new cases of psychiatric illness, stress can exacerbate existing illnesses (Pittenger and Duman 2008) and trigger relapse of drugseeking behaviors in humans and laboratory animals (Beardsley et al.”
Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder
Schloesser, R. J., Huang, J., Klein, P. S., & Manji, H. K. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301575 · Cited by 249
“Finally, the interested reader is referred to the chapter by Pittenger and Duman for an excellent, extensive discussion of the role of plasticity cascades in depression, and as targets for antidepressants (Pittenger and Duman, 2008).”
BackgroundMicroglia: An Interface between the Loss of Neuroplasticity and Depression
Singhal, G., & Baune, B. T. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00270 · Cited by 250
“…neurobiological changes during depression, such as loss of neuroplasticity and neuroprotection, are being studied in detail (Fuchs et al., 2004; Pittenger and Duman, 2008; Player et al., 2013; Malykhin and Coupland, 2015), the involvement of glial cells in triggering changes in the brain…”
BackgroundAdult Neurogenesis, Mental Health, and Mental Illness: Hope or Hype?: Figure 1.
Eisch, A. J., Cameron, H. A., Encinas, J. M., Meltzer, L. A., Ming, G.-L., & Overstreet-Wadiche, L. S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3798-08.2008 · Cited by 247
“Moreover, adult neurogenesis is altered in animal models of these disorders, and effective therapies often normalize these changes (Chen et al., 2000; Malberg et al., 2000; Eisch, 2002; Abrous et al., 2005; Pittenger and Duman, 2008).”
BackgroundLi, H., Xiang, Y., Zhu, Z., Wang, W., Jiang, Z., Zhao, M., Cheng, S., Pan, F., Liu, D., Ho, R. C. M., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02303-y · Cited by 251
“Neurons communicate with each other through synapses located on dendritic spines [24].”
BackgroundBiological hypotheses and biomarkers of bipolar disorder
Sigitova, E., Fišar, Z., Hroudová, J., Cikánková, T., & Raboch, J. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12476 · Cited by 235
“Neuroprogression is an important mechanism of BD, and neurotrophins are key regulators of neurogenesis and neuroplasticity.(2,70,122) The neurotrophic hypothesis postulates that mood disorders, such as BD, are associated with a lower activity of neurotrophic factors, such as BDNF.”
BackgroundSerotonin: A never-ending story
Olivier, B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.031 · Cited by 253
“…serotonin transporters (Piñeyro and Blier, 1999), downregulation of neurotransmitter receptors, changes in signal transduction (Price and Drevets, 2012), mobilization of neurotrophic factors (Pittinger and Duman, 2008; Duman and Li, 2012) and enhanced hippocampal neurogenesis (Sahay and Hen, 2007).”
BackgroundLin, Y.-C., & Koleske, A. J. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153204 · Cited by 248
A Time-Dependent History of Mood Disorders in a Murine Model of Neuropathic Pain
Yalcin, I., Bohren, Y., Waltisperger, E., Sage-Ciocca, D., Yin, J. C., Freund-Mercier, M.-J., & Barrot, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.017 · Cited by 237
From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder
Liu, B., Liu, J., Wang, M., Zhang, Y., & Li, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00305 · Cited by 249
Hippocampal Sirtuin 1 signaling mediates depression-like behavior
Abe-Higuchi, N., Uchida, S., Yamagata, H., Higuchi, F., Hobara, T., Hara, K., Kobayashi, A., & Watanabe, Y. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.009 · Cited by 247
Hu, W., Zhang, M., Czéh, B., Flügge, G., & Zhang, W. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.31 · Cited by 246
“Preclinical studies document that chronic stress has a significant impact on neuroplasticity in limbic brain areas and that these changes have been suggested to contribute to the pathophysiology of mood disorders (Drevets et al, 2008; McEwen, 2007; Pittenger and Duman, 2008).”
BackgroundPetrik, D., Lagace, D. C., & Eisch, A. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.003 · Cited by 241
“…is associated with decreased hippocampal neurogenesis and depressive- or anxious-like phenotypes (e.g. Ho and Wang, 2010; Lucassen et al., 2010a; Pittenger and Duman, 2008; Vollmayr et al., 2007), and that antidepressants can reverse the behavioral or cellular phenotype (e.g. Dagyte et al.,…”
BackgroundBlood microRNA changes in depressed patients during antidepressant treatment
Bocchio-Chiavetto, L., Maffioletti, E., Bettinsoli, P., Giovannini, C., Bignotti, S., Tardito, D., Corrada, D., Milanesi, L., & Gennarelli, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.013 · Cited by 238
Cellular and molecular basis for stress-induced depression
Seo, J.-S., Wei, J., Qin, L., Kim, Y., Yan, Z., & Greengard, P. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.118 · Cited by 235
“1, 2, 3, 5, 6 Our previous studies have implicated p11 as an important molecule involved in the etiology of depression and the mechanism of action of antidepressants.”
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression
Francis, T. C., & Lobo, M. K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.007 · Cited by 230
“While acute stress can be adaptive, chronic stress can be biologically damaging, making it a leading factor in the development of depression (11).”
BackgroundPolter, A., Beurel, E., Yang, S., Garner, R., Song, L., Miller, C. A., Sweatt, J. D., McMahon, L., Bartolucci, A. A., Li, X., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.43 · Cited by 225
“The pathophysiological mechanisms underlying bipolar disorder are unknown, but may include genetic variations, abnormal development of neural networks, and dysregulation of neurotransmitter, neuroendocrine, and signaling activities (Gold and Chrousos, 2002; Martinowich et al, 2009; Pittenger and Duman, 2008).”
BackgroundThe contribution of failing adult hippocampal neurogenesis to psychiatric disorders
Kempermann, G., Krebs, J., & Fabel, K. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282fad375 · Cited by 227
Brain NMDA Receptors in Schizophrenia and Depression
Adell, A. (2020) · Biomolecules · doi:10.3390/biom10060947 · Cited by 212
“Due to the important implication of neuronal plasticity [2,3], the present review is focused on the link between NMDARs and the pathophysiology and treatment of schizophrenia and depression.”
BackgroundA tractography analysis of two deep brain stimulation white matter targets for depression
Gutman, D. A., Holtzheimer, P. E., Behrens, T. E. J., Johansen-Berg, H., & Mayberg, H. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.021 · Cited by 220
Mathews, D. C., Henter, I. D., & Zarate, C. A. (2012) · Drugs · doi:10.2165/11633130-000000000-00000 · Cited by 220
“PFC, hippocampus, amygdala) of the CNS is thought to play a role in depression and anxiety.([46-49]) Given that glutamate is necessary for the normal development of dendritic branching,([50]) it has been speculated that excessive glutamatergic neurotransmission (via exposure to chronic stress) causes dendritic retract…”
BackgroundPathways Connecting Late-Life Depression and Dementia
Linnemann, C., & Lang, U. E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00279 · Cited by 210
Nordanskog, P., Dahlstrand, U., Larsson, M. R., Larsson, E.-M., Knutsson, L., & Johanson, A. (2010) · The Journal of ECT · doi:10.1097/yct.0b013e3181a95da8 · Cited by 219
“Reduced neurogenesis and glial changes in hippocampus have been proposed to play a key role in mood disorders.(2,3) Volume loss of the hippocampus has been shown to relate to depressive state,(4,5) depression duration,(6,7) and number of depressive episodes.”
BackgroundRole of CRF Receptor Signaling in Stress Vulnerability, Anxiety, and Depression
Hauger, R. L., Risbrough, V., Oakley, R. H., Olivares‐Reyes, J. A., & Dautzenberg, F. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05011.x · Cited by 217
Understanding stress: Insights from rodent models
Atrooz, F., Alkadhi, K. A., & Salim, S. (2021) · Current Research in Neurobiology · doi:10.1016/j.crneur.2021.100013 · Cited by 189
“(Plotsky and Meaney, 1993).”
Duman, R. S. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/rsduman · Cited by 210
Self-citationChildhood abuse and neglect and cognitive flexibility in adolescents
Spann, M. N., Mayes, L. C., Kalmar, J. H., Guiney, J., Womer, F. Y., Pittman, B., Mazure, C. M., Sinha, R., & Blumberg, H. P. (2012) · Child Neuropsychology · doi:10.1080/09297049.2011.595400 · Cited by 184
Metadata
- Authors
- Pittenger, C., & Duman, R. S.
- Affiliations
- Yale University (US)
- Corresponding author
- Duman, Ronald S
- Venue
- Neuropsychopharmacology
- Published
- 2007-09-12
- Volume
- 33
- Issue
- 1
- Pages
- 88-109
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1978891587
- Cited by
- 1,795
- References
- 257
- Citations by year
- 2026: 48 · 2025: 77 · 2024: 83 · 2023: 73 · 2022: 98 · 2021: 137 · 2020: 107 · 2019: 95 · 2018: 97 · 2017: 105 · 2016: 97 · 2015: 99 · 2014: 112 · 2013: 108 · 2012: 147
- FWCI
- 6.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- chronic stress, depression, neuroplasticity, antidepressants, structural plasticity, adult neurogenesis, synaptic plasticity, dendritic spine morphology, mood disorders, animal models of stress, depression pathophysiology
- MeSH terms
- Animals, Depression, Humans, Learning Disabilities, Memory Disorders, Models, Neurological, Neuronal Plasticity, Neurons, Stress, Physiological, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.